Back to top

oncology-screening: Archive

Kevin Cook

Bull of the Day: NVIDIA (NVDA)

After Computex, I raised my price target to $200 because Wall Street still has no idea what's coming

NVDANegative Net Change

Zacks Equity Research

GSK Blenrep Combos for Multiple Myeloma Accepted for EU Review

GSK announces the acceptance of its regulatory filing, seeking the approval of Blenrep combinations for the treatment of relapsed or refractory multiple myeloma, for review in the EU.

GSKPositive Net Change JNJPositive Net Change RAPTPositive Net Change ANVSPositive Net Change

Shaun Pruitt

Top Medical Stocks to Buy for Growth & Performance

The medical sector is crawling with opportunity as indicated in its representation on the Zacks Rank #1 (Strong Buy) list.

HAEPositive Net Change HALOPositive Net Change NBIXPositive Net Change